全球物质使用障碍治疗覆盖率评估:世界精神健康调查分析
该研究基于26个国家具有代表性的社区家庭调查数据,评估12个月物质使用障碍的患病率及治疗覆盖情况。在70,880名参与者中,2.6%符合12个月物质使用障碍标准,仅7.1%接受了最低充分治疗,高收入国家为10.3%,中高收入国家为4.3%,低/中低收入国家为1.0%。
要点
- 12个月物质使用障碍患病率为2.6%,中高收入国家(3.3%)高于高收入(2.6%)和低/中低收入国家(2.0%)。
- 仅39.1%的患者认识到治疗需求,其中61.3%至少就诊一次,29.5%的就诊者获得最低充分治疗。
- 整体仅7.1%的患者获得最低充分治疗,治疗覆盖存在认识需求、就诊和依从三重障碍。
核心结论
- 仅少数物质使用障碍患者获得最低充分治疗,且治疗覆盖率随国家收入水平下降而显著降低。
- 治疗覆盖缺口涉及认识/感知治疗需求、认识需求后获得治疗、以及提供方与患者对充分治疗的依从三个障碍。
研究设计与样本
- 基于世界卫生组织世界精神健康调查(WMHS)在26个国家开展的代表性社区家庭调查,共纳入70,880名参与者。
- 评估12个月物质使用障碍(酒精或药物滥用/依赖)患病率、治疗需求认知、就诊比例及最低充分治疗比例。
主要发现
- 70,880名参与者中2.6%符合12个月物质使用障碍标准,中高收入国家为3.3%,高收入国家为2.6%,低/中低收入国家为2.0%。
- 39.1%的患者认识到治疗需求,高收入国家为43.1%,中高收入国家为35.6%,低/中低收入国家为31.5%。
- 认识需求者中61.3%至少就诊一次,其中29.5%获得最低充分治疗,高收入国家为35.3%,中高收入国家为20.3%,低/中低收入国家为8.6%。
- 全体患者中仅7.1%获得最低充分治疗,高收入国家为10.3%,中高收入国家为4.3%,低/中低收入国家为1.0%。
关键数值与推荐
- 12个月物质使用障碍患病率:总体2.6%,中高收入国家3.3%,高收入国家2.6%,低/中低收入国家2.0%。
- 治疗需求认知比例:总体39.1%,高收入国家43.1%,中高收入国家35.6%,低/中低收入国家31.5%。
- 认识需求者就诊比例61.3%;就诊者中最低充分治疗比例29.5%(高收入35.3%、中高收入20.3%、低/中低收入8.6%)。
- 全体患者最低充分治疗比例7.1%(高收入10.3%、中高收入4.3%、低/中低收入1.0%)。
临床怎么用
- 临床应主动评估物质使用障碍患者的治疗需求认知,针对未认识需求者开展动机干预。
- 对已认识需求者需优化就诊可及性,并在治疗过程中关注提供方与患者双方对充分治疗的依从。
- 治疗覆盖率的国际比较可以上述数据为基线,用于可持续发展目标相关指标的监测。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality ("minimally adequate treatment"). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.
引用
- Degenhardt L, Glantz M, Evans-Lacko S, et al. Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys. World Psychiatry. 2017. PMID: 28941090. doi:10.1002/wps.20457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。